CenterBook Partners LP Buys 35,237 Shares of U.S. Physical Therapy, Inc. $USPH

CenterBook Partners LP boosted its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 582.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 41,284 shares of the company’s stock after acquiring an additional 35,237 shares during the quarter. CenterBook Partners LP’s holdings in U.S. Physical Therapy were worth $3,224,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. JPMorgan Chase & Co. lifted its position in U.S. Physical Therapy by 106.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 109,837 shares of the company’s stock valued at $9,331,000 after acquiring an additional 56,752 shares in the last quarter. William Blair Investment Management LLC lifted its position in U.S. Physical Therapy by 7.2% in the 4th quarter. William Blair Investment Management LLC now owns 370,707 shares of the company’s stock valued at $28,949,000 after acquiring an additional 24,848 shares in the last quarter. Bahl & Gaynor Inc. lifted its position in U.S. Physical Therapy by 47.6% in the 3rd quarter. Bahl & Gaynor Inc. now owns 474,688 shares of the company’s stock valued at $40,325,000 after acquiring an additional 153,054 shares in the last quarter. M&T Bank Corp lifted its position in U.S. Physical Therapy by 172.7% in the 4th quarter. M&T Bank Corp now owns 28,676 shares of the company’s stock valued at $2,239,000 after acquiring an additional 18,159 shares in the last quarter. Finally, American Century Companies Inc. bought a new stake in U.S. Physical Therapy in the 3rd quarter valued at $21,940,000.

U.S. Physical Therapy Stock Down 3.0%

Shares of USPH stock opened at $61.56 on Tuesday. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.41. U.S. Physical Therapy, Inc. has a 1 year low of $58.19 and a 1 year high of $93.50. The firm’s fifty day moving average price is $69.07 and its two-hundred day moving average price is $76.46. The firm has a market capitalization of $936.87 million, a P/E ratio of 123.11, a PEG ratio of 1.75 and a beta of 1.16.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.09). U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The business had revenue of $198.29 million during the quarter, compared to analyst estimates of $200.94 million. During the same quarter in the previous year, the firm posted $0.48 earnings per share. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. On average, equities analysts predict that U.S. Physical Therapy, Inc. will post 2.99 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 22nd will be paid a $0.46 dividend. This represents a $1.84 annualized dividend and a yield of 3.0%. The ex-dividend date is Friday, May 22nd. U.S. Physical Therapy’s payout ratio is presently 368.00%.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Jefferies Financial Group raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Thursday, March 12th. Citigroup reaffirmed an “outperform” rating on shares of U.S. Physical Therapy in a research report on Friday, May 8th. Barrington Research lowered their price target on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 13th. Citizens Jmp lowered their price target on shares of U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating on the stock in a research note on Friday, May 8th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Friday, May 29th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, U.S. Physical Therapy presently has a consensus rating of “Moderate Buy” and a consensus target price of $97.50.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 662 shares of U.S. Physical Therapy stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $78.86, for a total value of $52,205.32. Following the sale, the chief operating officer directly owned 30,078 shares in the company, valued at approximately $2,371,951.08. The trade was a 2.15% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.40% of the company’s stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.